Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Our encouraging preclinical data underscore SL-325’s potential for DR3 blockade to provide potentially best-in-class clinical remission rates for IBD patients ... Disclosure Report an Issue Shattuck ...

A live webcast of the 24 th Annual Needham Virtual Healthcare Conference presentation will be available on the Events and Presentations section of the Company’s website. A replay of the webcast will ...

Patients with Crohn’s disease had high Epstein-Barr virus seropositivity in the preclinical period and at diagnosis of inflammatory bowel disease, according to results of a cohort study of military ...

A discrete choice experiment (DCE) revealed no meaningful difference in preference between dual biologic therapy (DBT) or monotherapy among patients with inflammatory bowel disease (IBD ...